INS and type 2 diabetes mellitus: Pioglitazone improved blood sugar control in T2DM patients by increasing insulin sensitivity and inhibiting lipid peroxidation, while Repaglinide reduced lipid peroxidation and increased total anti-oxidative capacity [34].